Pierre Roux de Lusignan

Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.

Cureety provides healthcare facilities, academic research groups and pharmaceutical industrials with a best-in class digital health platform and services to improve the follow-up and care of patients having cancer while fostering research programs in real-world conditions on innovative therapies.

i-Virtuals mission is to democratize remote, touchless vital sign measurement, making it accessible to industries across the board and transforming how vital health information is captured and leveraged. As leaders in signal processing, computer vision, and artificial intelligence, i-Virtual has developed innovative technology that enables vital sign measurements through a simple, contactless process. We were the first in the world to receive CE Class IIa certification for a medical device that captures key physiological data—including heart rate, heart rate variability, breathing rate, and stress level—from a 30-second video selfie. This list will continue to grow as we further enhance our technology and enter new markets. We are now expanding our offering with a powerful API, enabling application and platform developers across various industries to integrate our technology with shorter time-to-market and less overhead. This empowers developers to significantly enhance their solutions with touchless vital sign measurement capabilities, while making health data more accessible and actionable across diverse markets.

Sêmeia conçoit et met en œuvre des solutions d’accompagnement des patients atteints de maladies graves ou chroniques. Nous appliquons les dernières technologies d’intelligence artificielle (deep learning, sequence mining…) au service de l’expérience des patients. Leur accompagnement est personnalisé grâce aux modèles prédictifs des parcours patients, appuyés notamment sur les données de remboursement de l’Assurance Maladie. Les solutions Sêmeia identifient les patients les plus à risque (arrêt de traitement, ré-hospitalisations, complications…) et les périodes critiques (prise de certains médicaments, délai après une hospitalisation...) pour intervenir auprès d’eux de manière efficiente et adaptée. Associés à nos modèles prédictifs, les outils Sêmeia interagissent avec le patient et/ou le professionnel de santé au moment propice, avec le message approprié et via le canal le plus pertinent (digital, SMS, appels d’infirmières, entretiens pharmaceutiques…). Nos principaux clients sont les industriels, les sociétés savantes et l’Assurance Maladie.

Bienvenue sur la page officielle du groupe Malakoff Humanis. Suivez l’actualité du Groupe depuis nos annonces stratégiques jusqu’aux enseignements clés de nos études en passant par la découverte de nos différents services.

XENOTHERA is a biotechnology company based 21 rue La Nouë Bras de Fer, 44000 Nantes, France.

Health for People (H4P) is a e-health company specialized in health education and personalized care management. Thanks to our AI system and our education services, we can assist health actors (clinicians, pharmaceutical companies, insurance services, health institutions…) in providing their patients and clients with innovative and personalized education digital solution for enhanced care management. Our goal is to empower patients through knowledge to help them better manage their health, every step of the way.

Streamline access, organization, and sharing of medical data to enhance the quality of care and clinical research.

Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.

Cureety provides healthcare facilities, academic research groups and pharmaceutical industrials with a best-in class digital health platform and services to improve the follow-up and care of patients having cancer while fostering research programs in real-world conditions on innovative therapies.

i-Virtuals mission is to democratize remote, touchless vital sign measurement, making it accessible to industries across the board and transforming how vital health information is captured and leveraged. As leaders in signal processing, computer vision, and artificial intelligence, i-Virtual has developed innovative technology that enables vital sign measurements through a simple, contactless process. We were the first in the world to receive CE Class IIa certification for a medical device that captures key physiological data—including heart rate, heart rate variability, breathing rate, and stress level—from a 30-second video selfie. This list will continue to grow as we further enhance our technology and enter new markets. We are now expanding our offering with a powerful API, enabling application and platform developers across various industries to integrate our technology with shorter time-to-market and less overhead. This empowers developers to significantly enhance their solutions with touchless vital sign measurement capabilities, while making health data more accessible and actionable across diverse markets.

Sêmeia conçoit et met en œuvre des solutions d’accompagnement des patients atteints de maladies graves ou chroniques. Nous appliquons les dernières technologies d’intelligence artificielle (deep learning, sequence mining…) au service de l’expérience des patients. Leur accompagnement est personnalisé grâce aux modèles prédictifs des parcours patients, appuyés notamment sur les données de remboursement de l’Assurance Maladie. Les solutions Sêmeia identifient les patients les plus à risque (arrêt de traitement, ré-hospitalisations, complications…) et les périodes critiques (prise de certains médicaments, délai après une hospitalisation...) pour intervenir auprès d’eux de manière efficiente et adaptée. Associés à nos modèles prédictifs, les outils Sêmeia interagissent avec le patient et/ou le professionnel de santé au moment propice, avec le message approprié et via le canal le plus pertinent (digital, SMS, appels d’infirmières, entretiens pharmaceutiques…). Nos principaux clients sont les industriels, les sociétés savantes et l’Assurance Maladie.

Bienvenue sur la page officielle du groupe Malakoff Humanis. Suivez l’actualité du Groupe depuis nos annonces stratégiques jusqu’aux enseignements clés de nos études en passant par la découverte de nos différents services.